Paradoxical	O
physiological	O
responses	O
to	O
propranolol	B:C0033497
in	O
a	O
Rett	O
syndrome	I:C0035372
patient	O
:	O
a	O
case	O
report	O
.	O

Paradoxical	O
physiological	O
responses	O
to	O
propranolol	O
in	O
a	O
Rett	B:C0035372
syndrome	I:C0035372
patient	O
:	O
a	O
case	O
report	O
.	O

Rett	B:C0035372
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	B:C0035372
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	B:C2249692
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	B:C0173924
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	B:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	B:C0027765
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	B:C0003467
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	B:C0025362
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	B:C0023015
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	B:C0751265
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	B:C0038273
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	O
regression	I:C1836830
.	O

Rett	O
Syndrome	I:C0035372
(	O
Rett	O
Syndrome	I:C0035372
)	O
,	O
caused	O
by	O
a	O
loss	O
-	I:C2249692
of	I:C2249692
-	I:C2249692
function	I:C2249692
in	I:C2249692
the	I:C2249692
epigenetic	I:C2249692
modulator	I:C2249692
:	O
X	O
-	I:C0173924
linked	I:C0173924
methyl	I:C0173924
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
(	O
methyl	O
-	I:C0173924
CpG	I:C0173924
binding	I:C0173924
protein	I:C0173924
2	I:C0173924
)	O
,	O
is	O
a	O
pervasive	O
neurological	O
disorder	I:C0027765
characterized	O
by	O
compromised	O
brain	O
functions	O
,	O
anxiety	O
,	O
severe	O
mental	O
retardation	I:C0025362
,	O
language	O
and	O
learning	O
disabilities	I:C0751265
,	O
repetitive	O
stereotyped	I:C0038273
hand	I:C0038273
movements	I:C0038273
and	O
developmental	B:C1836830
regression	I:C1836830
.	O

An	O
imbalance	B:C1397014
in	O
the	O
sympathetic	O
and	O
the	O
parasympathetic	O
nervous	I:C0030510
system	I:C0030510
(	O
dysautonomia	O
)	O
and	O
the	O
resulting	O
autonomic	O
storms	I:C0030660
is	O
a	O
frequent	O
occurrence	O
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

An	O
imbalance	O
in	O
the	O
sympathetic	B:C0039044
and	O
the	O
parasympathetic	O
nervous	I:C0030510
system	I:C0030510
(	O
dysautonomia	O
)	O
and	O
the	O
resulting	O
autonomic	O
storms	I:C0030660
is	O
a	O
frequent	O
occurrence	O
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

An	O
imbalance	O
in	O
the	O
sympathetic	O
and	O
the	O
parasympathetic	B:C0030510
nervous	I:C0030510
system	I:C0030510
(	O
dysautonomia	O
)	O
and	O
the	O
resulting	O
autonomic	O
storms	I:C0030660
is	O
a	O
frequent	O
occurrence	O
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

An	O
imbalance	O
in	O
the	O
sympathetic	O
and	O
the	O
parasympathetic	O
nervous	I:C0030510
system	I:C0030510
(	O
dysautonomia	B:C0013363
)	O
and	O
the	O
resulting	O
autonomic	O
storms	I:C0030660
is	O
a	O
frequent	O
occurrence	O
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

An	O
imbalance	O
in	O
the	O
sympathetic	O
and	O
the	O
parasympathetic	O
nervous	I:C0030510
system	I:C0030510
(	O
dysautonomia	O
)	O
and	O
the	O
resulting	O
autonomic	B:C0030660
storms	I:C0030660
is	O
a	O
frequent	O
occurrence	O
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

An	O
imbalance	O
in	O
the	O
sympathetic	O
and	O
the	O
parasympathetic	O
nervous	I:C0030510
system	I:C0030510
(	O
dysautonomia	O
)	O
and	O
the	O
resulting	O
autonomic	O
storms	I:C0030660
is	O
a	O
frequent	O
occurrence	O
in	O
patients	O
with	O
Rett	B:C0035372
Syndrome	I:C0035372
.	O

The	O
prototypical	O
beta	B:C1254351
blocker	I:C1254351
propranolol	O
has	O
been	O
used	O
to	O
manage	O
sympathetic	O
hyperactivity	I:C2267069
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

The	O
prototypical	O
beta	O
blocker	I:C1254351
propranolol	B:C0033497
has	O
been	O
used	O
to	O
manage	O
sympathetic	O
hyperactivity	I:C2267069
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

The	O
prototypical	O
beta	O
blocker	I:C1254351
propranolol	O
has	O
been	O
used	O
to	O
manage	O
sympathetic	B:C2267069
hyperactivity	I:C2267069
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

The	O
prototypical	O
beta	O
blocker	I:C1254351
propranolol	O
has	O
been	O
used	O
to	O
manage	O
sympathetic	O
hyperactivity	I:C2267069
in	O
patients	O
with	O
Rett	B:C0035372
Syndrome	I:C0035372
.	O

A	O
13	O
year	O
old	O
girl	O
with	O
Rett	B:C0035372
Syndrome	I:C0035372
was	O
referred	O
to	O
the	O
Centre	O
for	O
Interventional	O
Paediatric	O
Psychopharmacology	O
and	O
Rare	O
Diseases	O
(	O
CIPPRD	O
)	O
,	O
South	O
London	O
and	O
Maudsley	O
NHS	O
Foundation	O
Trust	O
.	O

Her	O
clinical	B:C0422813
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	B:C1260922
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	B:C0020578
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	B:C0003578
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	B:C0014544
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	B:C0036439
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	B:C1513916
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	B:C0151878
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	B:C1623258
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	B:C1623258
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	B:C1513916
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	B:C0018798
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	B:C0429087
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	B:C0488377
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	O
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

Her	O
clinical	O
picture	I:C0422813
included	O
disordered	O
breathing	I:C1260922
with	O
concomitant	O
hyperventilation	O
and	O
apnoea	O
,	O
epilepsy	O
,	O
scoliosis	O
,	O
no	O
QT	O
prolongation	I:C0151878
(	O
QT	O
/	O
QTc	O
[	O
372/467	O
ms	O
on	O
automated	O
electrocardiogram	O
[	O
electrocardiogram	O
]	O
,	O
but	O
manually	O
calculated	O
to	O
be	O
440	O
ms	O
]	O
)	O
,	O
no	O
cardiac	O
abnormalities	I:C0018798
(	O
PR	O
interval	I:C0429087
:	O
104	O
ms	O
,	O
QRS	O
duration	I:C0488377
:	O
78	O
ms	O
)	O
,	O
and	O
generalised	B:C0270549
anxiety	I:C0270549
disorder	I:C0270549
(	O
ICD	O
-	O
10	O
-	O
CM	O
Diagnosis	O
Code	O
F41.1	O
)	O
.	O

She	O
was	O
also	O
constipated	B:C0009806
and	O
was	O
fed	O
via	O
percutaneous	O
endoscopic	I:C0176751
gastrostomy	I:C0176751
(	O
percutaneous	O
endoscopic	I:C0176751
gastrostomy	I:C0176751
)	O
.	O

She	O
was	O
also	O
constipated	O
and	O
was	O
fed	O
via	O
percutaneous	B:C0176751
endoscopic	I:C0176751
gastrostomy	I:C0176751
(	O
percutaneous	O
endoscopic	I:C0176751
gastrostomy	I:C0176751
)	O
.	O

She	O
was	O
also	O
constipated	O
and	O
was	O
fed	O
via	O
percutaneous	O
endoscopic	I:C0176751
gastrostomy	I:C0176751
(	O
percutaneous	B:C0176751
endoscopic	I:C0176751
gastrostomy	I:C0176751
)	O
.	O

To	O
manage	O
the	O
dysautonomia	B:C0013363
,	O
propranolol	O
was	O
given	O
(	O
5	O
mg	O
and	O
10	O
mg	O
)	O
and	O
in	O
parallel	O
her	O
physiological	O
parameters	I:C1269723
,	O
including	O
heart	O
rate	I:C0018810
,	O
skin	O
temperature	O
and	O
skin	O
transpiration	O
,	O
were	O
monitored	O
continuously	O
for	O
24	O
h	O
as	O
she	O
went	O
about	O
her	O
activities	O
of	O
daily	O
living	O
.	O

To	O
manage	O
the	O
dysautonomia	O
,	O
propranolol	B:C0033497
was	O
given	O
(	O
5	O
mg	O
and	O
10	O
mg	O
)	O
and	O
in	O
parallel	O
her	O
physiological	O
parameters	I:C1269723
,	O
including	O
heart	O
rate	I:C0018810
,	O
skin	O
temperature	O
and	O
skin	O
transpiration	O
,	O
were	O
monitored	O
continuously	O
for	O
24	O
h	O
as	O
she	O
went	O
about	O
her	O
activities	O
of	O
daily	O
living	O
.	O

To	O
manage	O
the	O
dysautonomia	O
,	O
propranolol	O
was	O
given	O
(	O
5	O
mg	O
and	O
10	O
mg	O
)	O
and	O
in	O
parallel	O
her	O
physiological	B:C1269723
parameters	I:C1269723
,	O
including	O
heart	O
rate	I:C0018810
,	O
skin	O
temperature	O
and	O
skin	O
transpiration	O
,	O
were	O
monitored	O
continuously	O
for	O
24	O
h	O
as	O
she	O
went	O
about	O
her	O
activities	O
of	O
daily	O
living	O
.	O

To	O
manage	O
the	O
dysautonomia	O
,	O
propranolol	O
was	O
given	O
(	O
5	O
mg	O
and	O
10	O
mg	O
)	O
and	O
in	O
parallel	O
her	O
physiological	O
parameters	I:C1269723
,	O
including	O
heart	B:C0018810
rate	I:C0018810
,	O
skin	O
temperature	O
and	O
skin	O
transpiration	O
,	O
were	O
monitored	O
continuously	O
for	O
24	O
h	O
as	O
she	O
went	O
about	O
her	O
activities	O
of	O
daily	O
living	O
.	O

To	O
manage	O
the	O
dysautonomia	O
,	O
propranolol	O
was	O
given	O
(	O
5	O
mg	O
and	O
10	O
mg	O
)	O
and	O
in	O
parallel	O
her	O
physiological	O
parameters	I:C1269723
,	O
including	O
heart	O
rate	I:C0018810
,	O
skin	O
temperature	O
and	O
skin	B:C1123023
transpiration	O
,	O
were	O
monitored	O
continuously	O
for	O
24	O
h	O
as	O
she	O
went	O
about	O
her	O
activities	O
of	O
daily	O
living	O
.	O

To	O
manage	O
the	O
dysautonomia	O
,	O
propranolol	O
was	O
given	O
(	O
5	O
mg	O
and	O
10	O
mg	O
)	O
and	O
in	O
parallel	O
her	O
physiological	O
parameters	I:C1269723
,	O
including	O
heart	O
rate	I:C0018810
,	O
skin	O
temperature	O
and	O
skin	O
transpiration	B:C1326386
,	O
were	O
monitored	O
continuously	O
for	O
24	O
h	O
as	O
she	O
went	O
about	O
her	O
activities	O
of	O
daily	O
living	O
.	O

Whilst	O
her	O
skin	B:C0232417
temperature	I:C0232417
increased	I:C0232417
and	O
skin	O
transpiration	O
decreased	O
,	O
unexpectedly	O
there	O
was	O
a	O
significant	O
paradoxical	O
increase	O
in	O
the	O
patient	O
's	O
average	O
heart	O
rate	I:C0018810
following	O
propranolol	O
treatment	O
.	O

Whilst	O
her	O
skin	O
temperature	I:C0232417
increased	I:C0232417
and	O
skin	B:C1123023
transpiration	O
decreased	O
,	O
unexpectedly	O
there	O
was	O
a	O
significant	O
paradoxical	O
increase	O
in	O
the	O
patient	O
's	O
average	O
heart	O
rate	I:C0018810
following	O
propranolol	O
treatment	O
.	O

Whilst	O
her	O
skin	O
temperature	I:C0232417
increased	I:C0232417
and	O
skin	O
transpiration	B:C1326386
decreased	O
,	O
unexpectedly	O
there	O
was	O
a	O
significant	O
paradoxical	O
increase	O
in	O
the	O
patient	O
's	O
average	O
heart	O
rate	I:C0018810
following	O
propranolol	O
treatment	O
.	O

Whilst	O
her	O
skin	O
temperature	I:C0232417
increased	I:C0232417
and	O
skin	O
transpiration	O
decreased	O
,	O
unexpectedly	O
there	O
was	O
a	O
significant	O
paradoxical	O
increase	O
in	O
the	O
patient	O
's	O
average	O
heart	B:C0018810
rate	I:C0018810
following	O
propranolol	O
treatment	O
.	O

Whilst	O
her	O
skin	O
temperature	I:C0232417
increased	I:C0232417
and	O
skin	O
transpiration	O
decreased	O
,	O
unexpectedly	O
there	O
was	O
a	O
significant	O
paradoxical	O
increase	O
in	O
the	O
patient	O
's	O
average	O
heart	O
rate	I:C0018810
following	O
propranolol	B:C0033497
treatment	O
.	O

Here	O
,	O
we	O
present	O
a	O
unique	O
case	O
of	O
a	O
paradoxical	O
increase	O
in	O
heart	B:C1997754
rate	I:C1997754
response	I:C1997754
following	O
propranolol	O
treatment	O
for	O
managing	O
dysautonomia	O
in	O
a	O
child	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

Here	O
,	O
we	O
present	O
a	O
unique	O
case	O
of	O
a	O
paradoxical	O
increase	O
in	O
heart	O
rate	I:C1997754
response	I:C1997754
following	O
propranolol	B:C0033497
treatment	O
for	O
managing	O
dysautonomia	O
in	O
a	O
child	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

Here	O
,	O
we	O
present	O
a	O
unique	O
case	O
of	O
a	O
paradoxical	O
increase	O
in	O
heart	O
rate	I:C1997754
response	I:C1997754
following	O
propranolol	O
treatment	O
for	O
managing	O
dysautonomia	B:C0013363
in	O
a	O
child	O
with	O
Rett	O
Syndrome	I:C0035372
.	O

Here	O
,	O
we	O
present	O
a	O
unique	O
case	O
of	O
a	O
paradoxical	O
increase	O
in	O
heart	O
rate	I:C1997754
response	I:C1997754
following	O
propranolol	O
treatment	O
for	O
managing	O
dysautonomia	O
in	O
a	O
child	O
with	O
Rett	B:C0035372
Syndrome	I:C0035372
.	O

Further	O
studies	O
are	O
warranted	O
to	O
better	O
understand	O
the	O
underlying	O
dysautonomia	B:C0013363
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
and	O
the	O
impact	O
this	O
might	O
have	O
on	O
treatment	O
strategies	I:C0040808
in	O
rare	O
disorders	O
such	O
as	O
Rett	O
Syndrome	I:C0035372
.	O

Further	O
studies	O
are	O
warranted	O
to	O
better	O
understand	O
the	O
underlying	O
dysautonomia	O
in	O
patients	O
with	O
Rett	B:C0035372
Syndrome	I:C0035372
and	O
the	O
impact	O
this	O
might	O
have	O
on	O
treatment	O
strategies	I:C0040808
in	O
rare	O
disorders	O
such	O
as	O
Rett	O
Syndrome	I:C0035372
.	O

Further	O
studies	O
are	O
warranted	O
to	O
better	O
understand	O
the	O
underlying	O
dysautonomia	O
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
and	O
the	O
impact	O
this	O
might	O
have	O
on	O
treatment	B:C0040808
strategies	I:C0040808
in	O
rare	O
disorders	O
such	O
as	O
Rett	O
Syndrome	I:C0035372
.	O

Further	O
studies	O
are	O
warranted	O
to	O
better	O
understand	O
the	O
underlying	O
dysautonomia	O
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
and	O
the	O
impact	O
this	O
might	O
have	O
on	O
treatment	O
strategies	I:C0040808
in	O
rare	O
disorders	B:C0012634
such	O
as	O
Rett	O
Syndrome	I:C0035372
.	O

Further	O
studies	O
are	O
warranted	O
to	O
better	O
understand	O
the	O
underlying	O
dysautonomia	O
in	O
patients	O
with	O
Rett	O
Syndrome	I:C0035372
and	O
the	O
impact	O
this	O
might	O
have	O
on	O
treatment	O
strategies	I:C0040808
in	O
rare	O
disorders	O
such	O
as	O
Rett	B:C0035372
Syndrome	I:C0035372
.	O

